“Conjunctivitis Does Not Increase With Longer Duration of Lebrikizumab Exposure in Patients With Moderate-to-Severe Atopic Dermatitis”. SKIN The Journal of Cutaneous Medicine, vol. 7, no. 6, Nov. 2023, p. s276, https://doi.org/10.25251/skin.7.supp.276.